RESA_PLAFF
ID RESA_PLAFF Reviewed; 1073 AA.
AC P13830;
DT 01-JAN-1990, integrated into UniProtKB/Swiss-Prot.
DT 01-JAN-1990, sequence version 1.
DT 25-MAY-2022, entry version 110.
DE RecName: Full=Ring-infected erythrocyte surface antigen;
DE Flags: Precursor;
GN Name=RESA;
OS Plasmodium falciparum (isolate FC27 / Papua New Guinea).
OC Eukaryota; Sar; Alveolata; Apicomplexa; Aconoidasida; Haemosporida;
OC Plasmodiidae; Plasmodium; Plasmodium (Laverania).
OX NCBI_TaxID=5837;
RN [1]
RP NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA].
RX PubMed=3537955; DOI=10.1093/nar/14.21.8265;
RA Favaloro J.M., Coppel R.L., Corcoran L.M., Foote S.J., Brown G.V.,
RA Anders R.F., Kemp D.J.;
RT "Structure of the RESA gene of Plasmodium falciparum.";
RL Nucleic Acids Res. 14:8265-8277(1986).
CC -!- FUNCTION: May disrupt the normal intermolecular interactions of the
CC cytoplasmic domain of band 3 and thereby facilitate the invagination of
CC the red cell membrane which is necessary for the formation of the
CC parasitophorous vacuole.
CC -!- SUBCELLULAR LOCATION: Cell membrane; Peripheral membrane protein;
CC Cytoplasmic side. Note=Probably located on the cytoplasmic face of the
CC membrane where it associates with components of the membrane skeleton.
CC -!- PTM: The Tyr residues in the variant tetrameric sequences in the RESA
CC repeat are possibly phosphorylated (by homology with band 3).
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; X04572; CAA28241.1; -; Genomic_DNA.
DR EMBL; X05182; CAA28817.1; -; mRNA.
DR PIR; A25526; A25526.
DR PDB; 2MUA; NMR; -; A=181-200.
DR PDBsum; 2MUA; -.
DR AlphaFoldDB; P13830; -.
DR BMRB; P13830; -.
DR SMR; P13830; -.
DR DrugBank; DB11638; Artenimol.
DR GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR CDD; cd06257; DnaJ; 1.
DR Gene3D; 1.10.287.110; -; 1.
DR Gene3D; 6.10.280.180; -; 1.
DR InterPro; IPR001623; DnaJ_domain.
DR InterPro; IPR018253; DnaJ_domain_CS.
DR InterPro; IPR026894; DnaJ_X.
DR InterPro; IPR036869; J_dom_sf.
DR InterPro; IPR019111; PRESA_N.
DR InterPro; IPR044885; PRESA_N_sf.
DR Pfam; PF00226; DnaJ; 1.
DR Pfam; PF14308; DnaJ-X; 1.
DR Pfam; PF09687; PRESAN; 1.
DR PRINTS; PR00625; JDOMAIN.
DR SMART; SM00271; DnaJ; 1.
DR SUPFAM; SSF46565; SSF46565; 1.
DR PROSITE; PS00636; DNAJ_1; 1.
DR PROSITE; PS50076; DNAJ_2; 1.
PE 1: Evidence at protein level;
KW 3D-structure; Cell membrane; Glycoprotein; Malaria; Membrane; Repeat;
KW Signal.
FT SIGNAL 1..65
FT CHAIN 66..1073
FT /note="Ring-infected erythrocyte surface antigen"
FT /id="PRO_0000007271"
FT DOMAIN 521..589
FT /note="J"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00286"
FT REGION 428..514
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT REGION 436..504
FT /note="Tandem repeats 1"
FT REGION 891..1073
FT /note="Tandem repeats 2"
FT REGION 894..1073
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT COMPBIAS 430..444
FT /note="Acidic residues"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT COMPBIAS 445..505
FT /note="Basic and acidic residues"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT COMPBIAS 894..926
FT /note="Basic and acidic residues"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT COMPBIAS 927..1073
FT /note="Acidic residues"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT CARBOHYD 71
FT /note="N-linked (GlcNAc...) asparagine"
FT /evidence="ECO:0000255"
FT CARBOHYD 639
FT /note="N-linked (GlcNAc...) asparagine"
FT /evidence="ECO:0000255"
FT CARBOHYD 773
FT /note="N-linked (GlcNAc...) asparagine"
FT /evidence="ECO:0000255"
FT CARBOHYD 777
FT /note="N-linked (GlcNAc...) asparagine"
FT /evidence="ECO:0000255"
FT HELIX 184..199
FT /evidence="ECO:0007829|PDB:2MUA"
SQ SEQUENCE 1073 AA; 124907 MW; A4D3C37E10BA6D90 CRC64;
MRPFHAYSWI FSQQYMGTKN VKEKNPTIYS FDDEEKRNEN KSFLKVLCSK RGVLPIIGIL
YIILNGNLGY NGSSSSGVQF TDRCSRNLYG ETLPVNPYAD SENPIVVSQV FGLPFEKPTF
TLESPPDIDH TNILGFNEKF MTDVNRYRYS NNYEAIPHIS EFNPLIVDKV LFDYNEKVDN
LGRSGGDIIK KMQTLWDEIM DINKRKYDSL KEKLQKTYSQ YKVQYDMPKE AYESKWTQCI
KLIDQGGENL EERLNSQFKN WYRQKYLNLE EYRRLTVLNQ IAWKALSNQI QYSCRKIMNS
DISSFKHINE LKSLEHRAAK AAEAEMKKRA QKPKKKKSRR GWLCCGGGDI ETVEPQQEEP
VQTVQEQQVN EYGDILPSLR ASITNSAINY YDTVKDGVYL DHETSDALYT DEDLLFDLEK
QKYMDMLDTS EEESVEENEE EHTVDDEHVE EHTADDEHVE EPTVADDEHV EEPTVADEHV
EEPTVAEEHV EEPTVAEEHV EEPASDVQQT SEAAPTIEIP DTLYYDILGV GVNADMNEIT
ERYFKLAENY YPYQRSGSTV FHNFRKVNEA YQVLGDIDKK RWYNKYGYDG IKQVNFMNPS
IFYLLSSLEK FKDFTGTPQI VTLLRFFFEK RLSMNDLENK SEHLLKFMEQ YQKEREAHVS
EYLLNILQPC IAGDSKWNVP IITKLEGLKG SRFDIPILES LRWIFKHVAK THLKKSSKSA
KKLQQRTQAN KQELANINNN LMSTLKEYLG SSEQMNSITY NFENINSNVD NGNQSKNISD
LSYTDQKEIL EKIVSYIVDI SLYDIENTAL NAAEQLLSDN SVDEKTLKKR AQSLKKLSSI
MERYAGGKRN DKKSKNFDTK DIVGYIMHGI STINTEMKNQ NENVPEHVQH NAEENVEHDA
EENVEHDAEE NVEHDAEENV EHDAEENVEH DAEENVEENV EEVEENVEEN VEENVEENVE
EVEENVEENV EENVEENVEE NVEENVEENV EENVEENVEE YDEENVEEVE ENVEENVEEN
VEENVEENVE EVEENVEENV EENVEENVEE NVEENVEEYD EENVEEHNEE YDE